{"id":"W2954372606","doi":"10.1080/21678421.2019.1632346","title":"Masitinib as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomized clinical trial","year":2019,"lang":"en","type":"article","venue":"Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":222,"is_retracted":false,"has_abstract":true,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"Fundación Española para el Fomento de la Investigación de la Esclerosis Lateral Amiotrófica","keywords":"Medicine; Internal medicine; Clinical endpoint; Population; Amyotrophic lateral sclerosis; Placebo; Cohort; Riluzole; Tolerability; Randomized controlled trial; Oncology; Adverse effect; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002025789,0.0008591223,0.002120576,0.0004874444,0.000268443,0.0004333736,0.0003538524,0.000597014,0.0007191784],"category_scores_gemma":[0.0001411141,0.0005924063,0.0004042715,0.0005758263,0.0002993515,0.0009568699,0.0001480982,0.0008869609,0.000320389],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003167801,"about_ca_system_score_gemma":0.0002138281,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00145564,"about_ca_topic_score_gemma":0.0002055311,"domain_scores_codex":[0.9921774,0.001604261,0.001849151,0.001740614,0.001488113,0.001140446],"domain_scores_gemma":[0.9969816,0.000168513,0.0004191971,0.001034367,0.0004034487,0.0009929223],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.7324058,0.002019437,0.2454248,0.00003754499,0.0002414813,0.00002217567,0.000500141,0.0002331934,0.00565235,0.0003541377,0.0002885821,0.01282037],"study_design_scores_gemma":[0.3811476,0.01197042,0.6038971,0.0004197611,0.00005955757,0.000003037451,0.00001147304,0.001478998,0.000191836,0.0001295477,0.0001218649,0.0005687856],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9894502,0.0001628112,0.00003820892,0.001930833,0.000663402,0.00734182,0.00004048149,0.0001510425,0.0002212419],"genre_scores_gemma":[0.9924568,0.0004901938,0.001106799,0.003190817,0.0009115688,0.000533786,0.0005035249,0.0001563977,0.0006501226],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3584723,"threshold_uncertainty_score":0.9996527,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05266457784771603,"score_gpt":0.3135612327284365,"score_spread":0.2608966548807204,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}